Market Overview

Bank Of America Downgrades Elanco Animal Health, Says Too Much Uncertainty Around Bayer Deal

Share:
Bank Of America Downgrades Elanco Animal Health, Says Too Much Uncertainty Around Bayer Deal

Last week, Elanco Animal Health Incorporated (NYSE: ELAN) announced plans to acquire Bayer’s (OTC: BAYRY) Animal Health business for $7.6 billion.

Although the deal was widely expected, and some details are better than expected, there are questions around the deal that are unlikely to be answered anytime soon, according Bank of America.

The Analyst

BofA’s Michael Ryskin downgraded Elanco Animal Health to Neutral while establishing a new price target of $30.

The Thesis

The purchase price of Elanco Animal Health’s deal to acquire Bayer’s Animal Health business is much lower than what some reports had speculated, Ryskin said in the note.

Mentioning other positives of the deal, the analyst said the combined entity’s margin profile is better than anticipated, while the headwinds to growth would likely be less than expected.

The deal could cause some near-term hurdles but is expected to “potentially turn out quite positively in the out-years,” Ryskin wrote. He added, however, that there is significant uncertainty, such as which parts of the portfolio will be divested to take care of antitrust issues and what is the “true go-forward growth rate of the business.”

These questions are likely to remain unanswered until the deal draws nearer to a close, which is expected in mid-2020. Ryskin recommended moving to the sidelines while waiting for more clarity on the deal.

Price Action

Shares of Elanco Animal Health had declined 1.8% to $25.91 at time of publishing.

Related Links:

Elanco To Acquire Bayer's Animal Health Business For $7.6B

Benzinga's Top Upgrades, Downgrades For August 26, 2019

Latest Ratings for ELAN

DateFirmActionFromTo
Nov 2019UpgradesEqual-WeightOverweight
Sep 2019Initiates Coverage OnOverweight
Aug 2019DowngradesBuyNeutral

View More Analyst Ratings for ELAN
View the Latest Analyst Ratings

Posted-In: Bank of America Michael RyskinAnalyst Color Downgrades Price Target Analyst Ratings Best of Benzinga

 

Related Articles (BAYRY + ELAN)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
NVDACascendMaintains240.0
NXTCBank of AmericaReiterates89.0
RNRJP MorganAssumes173.0
CARBNorthlandDowngrades23.0
GLIBACitiUpgrades80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

G-7 Commits $22M For Firefighting In Amazon Rainforest

Apple Analyst On Tariff Escalation: The 'Nightmare That Doesn't Go Away'